| Literature DB >> 28384548 |
Jing Tang1, Sanjeev Kumar V Vernekar1, Yue-Lei Chen1, Lena Miller2, Andrew D Huber3, Nataliya Myshakina4, Stefan G Sarafianos5, Michael A Parniak2, Zhengqiang Wang6.
Abstract
Human immunodeficiency virus (HIV) reverse transcriptase (RT) associated ribonuclease H (RNase H) remains the only virally encoded enzymatic function not clinically validated as an antiviral target. 2-Hydroxyisoquinoline-1,3-dione (HID) is known to confer active site directed inhibition of divalent metal-dependent enzymatic functions, such as HIV RNase H, integrase (IN) and hepatitis C virus (HCV) NS5B polymerase. We report herein the synthesis and biochemical evaluation of a few C-5, C-6 or C-7 substituted HID subtypes as HIV RNase H inhibitors. Our data indicate that while some of these subtypes inhibited both the RNase H and polymerase (pol) functions of RT, potent and selective RNase H inhibition was achieved with subtypes 8-9 as exemplified with compounds 8c and 9c.Entities:
Keywords: 2-hydroxyisoquinoline-1,3-diones; HIV; Inhibitor; RNase H; Reverse transcriptase
Mesh:
Substances:
Year: 2017 PMID: 28384548 PMCID: PMC5539924 DOI: 10.1016/j.ejmech.2017.03.059
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514